Y
Yuguang Song
Researcher at Capital Medical University
Publications - 12
Citations - 167
Yuguang Song is an academic researcher from Capital Medical University. The author has contributed to research in topics: Immunotherapy & Cytotoxic T cell. The author has an hindex of 5, co-authored 10 publications receiving 114 citations.
Papers
More filters
Journal ArticleDOI
Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
Ni Jiang,Guoliang Qiao,Xiaoli Wang,Michael A. Morse,William R. Gwin,Lei Zhou,Yuguang Song,Yanjie Zhao,Feng Chen,Xinna Zhou,Lefu Huang,Amy Hobeika,Xin Yi,Xuefeng Xia,Yanfang Guan,Jin Song,Jun Ren,Jun Ren,H. Kim Lyerly +18 more
TL;DR: Treatment of advanced pancreatic cancer with combined DC-CIK infusions and S-1 was safe, resulted in favorable PFS and OS, and modulated the peripheral blood immune repertoire.
Journal ArticleDOI
Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study.
Guoliang Qiao,Xiaoli Wang,Lei Zhou,Xinna Zhou,Yuguang Song,Shuo Wang,Lei Zhao,Michael A. Morse,Amy Hobeika,Jin Song,Xin Yi,Xuefeng Xia,Jun Ren,Jun Ren,Herbert Kim Lyerly +14 more
TL;DR: Clinical efficacy correlated with decreases in ctDNA mutational profiles and restored TCR repertoire and the combination therapy was safe with tolerable toxicities.
Journal ArticleDOI
Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients’ preference-based study (PPPS)
Yanjie Zhao,Guoliang Qiao,Xiaoli Wang,Yuguang Song,Xinna Zhou,Ni Jiang,Lei Zhou,Hongyan Huang,Jing Zhao,Michael A. Morse,Amy Hobeika,Jun Ren,Jun Ren,Herbert Kim Lyerly +13 more
TL;DR: DC-CIK combined with chemotherapy administration resulted in numerically superior PFS and OS compared with monotherapy in advanced NSCLC.
Journal ArticleDOI
Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors.
Guoliang Qiao,Xiaoli Wang,Xinna Zhou,Michael A. Morse,Jiangping Wu,Shuo Wang,Yuguang Song,Ni Jiang,Yanjie Zhao,Lei Zhou,Jing Zhao,Yan Di,Lihong Zhu,Amy Hobeika,Jun Ren,Jun Ren,Herbert Kim Lyerly +16 more
TL;DR: Combining HT with ACT plus either CT or anti-PD-1 antibody was safe, generated clinical responses in previously treated advanced cancers, and promoted TCR repertoire diversity and favorable changes in serum IL-2, IL-4, TNF-α, and IFN-γ levels in clinical responders.
Journal ArticleDOI
Continuous DC-CIK infusions restore CD8+ cellular immunity, physical activity and improve clinical efficacy in advanced cancer patients unresponsive to conventional treatments.
Yanjie Zhao,Ni Jiang,Qingkun Song,Jiangping Wu,Yuguang Song,Hongmei Zhang,Feng Chen,Lei Zhou,Xiaoli Wang,Xinna Zhou,Huabing Yang,Jun Ren,Herbert Kim Lyerly +12 more
TL;DR: In advanced cancer patients, continuous dendritic cell-cytokine induced killer cell infusions are capable of recovering cellular immunity, improving patient status and quality of life in those who are unresponsive to conventional cancer treatment.